On January 4, 2019, Ding Shaoxiong, Vice Chairman of Lishui Municipal Political Consultative Conference, led a delegation to visit Zhejiang Benefit Pharmaceutical Co., Ltd. for research and guidance. Wu Lihua, Chairman of the company, Guo Lianping, Deputy General Manager of Projects, and other senior executives accompanied the research.

Ms. Zhang Liyun, Chief Administrative Officer of the company, first gave a brief report to Vice Chairman Ding Shaoxiong on the company's current operation status, industrial innovation, cultural development, etc. Through the remote video system, she showed the delegation the various production process links, inspection and R&D situations of Benefit Pharmaceutical. In addition, exchanges were conducted on the current development of the traditional Chinese medicine industry, as well as the practices and experiences in promoting the clustered development of the traditional Chinese medicine industry.

At the symposium, Chairman Wu Lihua first reported to Vice Chairman Ding Shaoxiong and his delegation on the development of Benefit Pharmaceutical in 2018 and the business goals for the next two years. He also elaborated on the three development directions of the enterprise in combination with local medicinal materials in Lishui, namely "producing high-quality products", "building brands" and "promoting industries". He pointed out the advantages of the current traditional Chinese medicine formula granules, such as convenient administration, easy portability, definite curative effect and stable quality. Meanwhile, he introduced the advantages and uniqueness of the company's current products that are both medicinal and edible. He also explained that while the enterprise is continuously innovating and developing, in the R&D and production of genuine medicinal materials such as traditional Chinese medicine formula granules and She medicine, it has been continuously combining with agricultural cooperatives to carry out a new large-scale, professional and industrialized under-forest economic model of "local agricultural cooperatives - enterprise bases", so as to promote the clustered development of the local traditional Chinese medicine industry. It will continue to build a high-quality, innovative and international Benefit Pharmaceutical in the future.

In the process of continuous and rapid development, Chairman Wu Lihua also pointed out that Benefit is fully aware of the importance of cultivating "its own talents". In the future, it will continue to pay more attention to talents, and expressed his expectation to cultivate a group of outstanding talents who will take root and grow in Benefit in the future.

Vice Chairman Ding Shaoxiong highly affirmed the development and planning of Benefit Pharmaceutical, praised its valuable persistence in accumulating strength for development, respecting talents and attaching importance to science and technology, and also expressed good wishes for the future development of Benefit Pharmaceutical.